We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+14.58%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$378M
AUM Growth
+$22.7M
Cap. Flow
-$2.63M
Cap. Flow %
-0.7%
Top 10 Hldgs %
31.74%
Holding
97
New
18
Increased
35
Reduced
31
Closed
13

Top Buys

Rank Stock Value
1
MASI
Masimo
MASI
+$7.85M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$5.39M
3
IMUX icon
Immunic
IMUX
+$4.26M
4
ETNB
89bio
ETNB
+$3.49M
5
SDC
SmileDirectClub, Inc. Class A Common Stock
SDC
+$3.31M

Top Sells

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$8.03M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$6.37M
3
GNMK
GenMark Diagnostics, Inc
GNMK
+$4.89M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$3.45M
5
NVAX icon
Novavax
NVAX
+$2.74M

Sector Composition

Rank Sector Weight
1 Healthcare 92.08%
2 Technology 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARWR icon
51
Arrowhead Research
ARWR
$12.3B
$2.58M 0.68%
+60,000
New +$2.59M
AXSM icon
52
Axsome Therapeutics
AXSM
$11.2B
$2.49M 0.66%
35,010
-4,990
-12% -$389K
SDGR icon
53
Schrodinger
SDGR
$1.39B
$2.38M 0.63%
50,000
+35,000
+233% +$2.41M
KALA icon
54
KALA BIO
KALA
$17.1M
$2.33M 0.62%
124
+14
+13% +$322K
STXS icon
55
Stereotaxis
STXS
$139M
$2.31M 0.61%
643,813
-24,880
-4% -$95.9K
MDGL icon
56
Madrigal Pharmaceuticals
MDGL
$12.4B
$2.16M 0.57%
18,211
-31,789
-64% -$3.45M
STRO icon
57
Sutro Biopharma
STRO
$353M
$2.11M 0.56%
+21,000
New +$1.98M
TECX
58
Tectonic Therapeutic
TECX
$720M
$2.09M 0.55%
13,385
-2,498
-16% -$503K
EIDX
59
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$2.08M 0.55%
41,091
+6
+0% +$270
AUPH icon
60
Aurinia Pharmaceuticals
AUPH
$2.06B
$1.92M 0.51%
130,312
+24
+0% +$348
NVAX icon
61
Novavax
NVAX
$1.31B
$1.9M 0.5%
17,500
-22,500
-56% -$2.74M
NEPH icon
62
Nephros
NEPH
$47.4M
$1.75M 0.46%
241,411
-9,955
-4% -$72.8K
MGTX icon
63
MeiraGTx Holdings
MGTX
$1.2B
$1.73M 0.46%
130,763
-4,237
-3% -$55.8K
MSON
64
DELISTED
Misonix Inc
MSON
$1.59M 0.42%
135,596
+5,599
+4% +$72.7K
CSTL icon
65
Castle Biosciences
CSTL
$960M
$1.54M 0.41%
30,003
+5,003
+20% +$223K
AXGN icon
66
Axogen
AXGN
$2.67B
$1.45M 0.39%
+125,000
New +$1.45M
SURF
67
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1.38M 0.37%
200,019
+75,019
+60% +$455K
INOV
68
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$1.32M 0.35%
+50,000
New +$1.17M
PROF
69
Profound Medical
PROF
$252M
$1.24M 0.33%
+70,000
New +$1.11M
QDEL icon
70
QuidelOrtho
QDEL
$1.02B
$1.1M 0.29%
5,001
-999
-17% -$223K
RAPT
71
DELISTED
RAPT Therapeutics
RAPT
$966K 0.26%
3,751
-1,249
-25% -$277K
ATXS
72
DELISTED
Astria Therapeutics
ATXS
$901K 0.24%
24,250
-1,662
-6% -$65.9K
GYRE icon
73
Gyre Therapeutics
GYRE
$706M
$896K 0.24%
27,797
-901
-3% -$35.3K
DVAX
74
DELISTED
Dynavax Technologies
DVAX
$864K 0.23%
+200,000
New +$1.43M
MNKD icon
75
MannKind Corp
MNKD
$1.24B
$660K 0.17%
351,230
-199,887
-36% -$346K
1 2
3
4

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Parkman Healthcare Partners held 97 positions worth $378M, up 6.4% from $355M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parkman Healthcare Partners's Q3 2020 filing shows 18 new, 35 increased, 31 reduced and 13 closed positions. Its largest new stake was Masimo: 35,000 shares worth $8.26M. The largest sale was GW Pharmaceuticals Plc American Depositary Shares, an estimated $8.03M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 90% a quarter earlier, followed by Technology.

  • Parkman Healthcare Partners's largest Q3 2020 buy was Masimo: 35,000 shares worth $8.26M.
  • Parkman Healthcare Partners added most to Immunic in Q3 2020, an estimated $4.26M increase.
  • Parkman Healthcare Partners's biggest Q3 2020 reduction was GW Pharmaceuticals Plc American Depositary Shares, cutting an estimated $8.03M.
  • Parkman Healthcare Partners fully exited Seagen Inc. Common Stock in Q3 2020, selling an estimated $6.37M.
  • Parkman Healthcare Partners's ten largest holdings make up 32% of its $378M portfolio in Q3 2020.
  • Parkman Healthcare Partners opened 18 new positions and closed 13 in Q3 2020.
  • Parkman Healthcare Partners's portfolio value rose 6.4% quarter-over-quarter to $378M.

Based on Parkman Healthcare Partners's 13F filing for Q3 2020, filed 13 Nov 2020.